Program Information
Evaluating the Toxicity Reduction with CT-Ventilation Functional Avoidance Radiation Therapy
Y Vinogradskiy1*, Y Miyasaka2 , N Kadoya2 , R Castillo3 , E Castillo4 , T Guerrero4 , T Yamamoto5 , (1) University of Colorado Denver, Aurora, CO, (2) Tohoku University Graduate School of Medicine, Sendal, Miyagi, (3) University Texas Medical Branch of Galveston, League City, TX, (4) Beaumont Health System, Royal Oak, Michigan, (5) UC Davis School of Medicine, Sacramento, CA
Presentations
WE-AB-202-1 (Wednesday, August 3, 2016) 7:30 AM - 9:30 AM Room: 202
Purpose: CT-ventilation is an exciting new imaging modality that uses 4DCTs to calculate lung ventilation. Studies have proposed to use 4DCT-ventilation imaging for functional avoidance radiotherapy which implies designing treatment plans to spare functional portions of the lung. Although retrospective studies have been performed to evaluate the dosimetric gains to functional lung; no work has been done to translate the dosimetric gains to an improvement in pulmonary toxicity. The purpose of our work was to evaluate the potential reduction in toxicity for 4DCT-ventilation based functional avoidance.
Methods: 70 lung cancer patients with 4DCT imaging were used for the study. CT-ventilation maps were calculated using the patient’s 4DCT, deformable image registrations, and a density-change-based algorithm. Radiation pneumonitis was graded using imaging and clinical information. Log-likelihood methods were used to fit a normal-tissue-complication-probability (NTCP) model predicting grade 2+ radiation pneumonitis as a function of doses (mean and V20) to functional lung (>15% ventilation). For 20 patients a functional plan was generated that reduced dose to functional lung while meeting RTOG 0617-based constraints. The NTCP model was applied to the functional plan to determine the reduction in toxicity with functional planning
Results: The mean dose to functional lung was 16.8 and 17.7 Gy with the functional and clinical plans respectively. The corresponding grade 2+ pneumonitis probability was 26.9% with the clinically-used plan and 24.6% with the functional plan (8.5% reduction). The V20-based grade 2+ pneumonitis probability was 23.7% with the clinically-used plan and reduced to 19.6% with the functional plan (20.9% reduction).
Conclusion: Our results revealed a reduction of 9-20% in complication probability with functional planning. To our knowledge this is the first study to apply complication probability to convert dosimetric results to toxicity improvement. The results presented in the current work provide seminal data for prospective clinical trials in functional avoidance.
Funding Support, Disclosures, and Conflict of Interest: YV discloses funding from State of Colorado. TY discloses National Lung Cancer Partnership Young Investigator Research grant
Contact Email: